Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study

EJHaem. 2024 Jul 23;5(4):887-891. doi: 10.1002/jha2.946. eCollection 2024 Aug.

Authors

Cyrille Hulin¹, Nadia Quignot², Heng Jiang², Hakima Mechiche³, Gaëlle Désaméricq³

Affiliations

¹ Hematology unit Hospital Center University De Bordeaux Bordeaux France.
² Certara Evidence & Access Paris France.
³ Amgen SAS Boulogne-Billancourt France.

No abstract available